|
 |
FDA Approval Activities for this Drug…
Orfadin (Nitisinone) Capsules, Swedish Orphan, (R&R Registration is the U.S. Agent NDA 21-232 1/18/02 2/5/02 2/5/02 2/28/02 Orfadin Indications: An adjunct to dietary restriction of tyrosine and phenylalanine in the treatment of hereditary tyrosinemia tyep 1.
For the most up-to-date approval information, please locate this API using the drug index. |
|
|